Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Investigative Radiology
|
May 22, 2002
Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats
Laurent Lemaire, Jacqueline Fournier, Christian Ponthus, et al.
Blood Advances
|
February 13, 2018
C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia
Justin Loke, Paulynn Suyin Chin, Peter Keane, et al.
Frontiers in Immunology
|
June 10, 2021
Stable Epigenetic Programming of Effector and Central Memory CD4 T Cells Occurs Within 7 Days of Antigen Exposure <i>In Vivo</i>
Sarah L Bevington, Remi Fiancette, Dominika W Gajdasik, et al.
The EMBO Journal
|
September 15, 2020
IL-2/IL-7-inducible factors pioneer the path to T cell differentiation in advance of lineage-defining factors
Sarah L Bevington, Peter Keane, Jake K Soley, et al.
Leukemia
|
November 5, 2022
Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
Assunta Adamo, Paulynn Chin, Peter Keane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 27, 2007
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders
Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
Daniel J L Coleman, Peter Keane, Rosario Luque-Martin, et al.
Cell Reports
|
December 17, 2023
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
Daniel J L Coleman, Peter Keane, Rosario Luque-Martin, et al.
Iscience
|
April 19, 2024
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
Daniel J L Coleman, Peter Keane, Paulynn S Chin, et al.
Nature Communications
|
February 14, 2024
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth
Sophie G Kellaway, Sandeep Potluri, Peter Keane, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Investigative Radiology
|
May 22, 2002
Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats
Laurent Lemaire, Jacqueline Fournier, Christian Ponthus, et al.
Blood Advances
|
February 13, 2018
C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia
Justin Loke, Paulynn Suyin Chin, Peter Keane, et al.
Frontiers in Immunology
|
June 10, 2021
Stable Epigenetic Programming of Effector and Central Memory CD4 T Cells Occurs Within 7 Days of Antigen Exposure <i>In Vivo</i>
Sarah L Bevington, Remi Fiancette, Dominika W Gajdasik, et al.
The EMBO Journal
|
September 15, 2020
IL-2/IL-7-inducible factors pioneer the path to T cell differentiation in advance of lineage-defining factors
Sarah L Bevington, Peter Keane, Jake K Soley, et al.
Leukemia
|
November 5, 2022
Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
Assunta Adamo, Paulynn Chin, Peter Keane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 27, 2007
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders
Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
Daniel J L Coleman, Peter Keane, Rosario Luque-Martin, et al.
Cell Reports
|
December 17, 2023
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
Daniel J L Coleman, Peter Keane, Rosario Luque-Martin, et al.
Iscience
|
April 19, 2024
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
Daniel J L Coleman, Peter Keane, Paulynn S Chin, et al.
Nature Communications
|
February 14, 2024
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth
Sophie G Kellaway, Sandeep Potluri, Peter Keane, et al.
Page
of 3